NR4A1 and cardiac hypertrophy: This study reveals the existence of cross-talk mechanisms between TR3 and the TSC that function in the regulation of mTOR signalling and demonstrates a novel physiological function for TR3 that may qualify it as a clinical target for the treatment of cardiac hypertrophy.